Shunt reduction with a fenestrated Amplatzer device
- 19 March 2010
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 76 (4), 564-571
- https://doi.org/10.1002/ccd.22556
Abstract
Background: In specific high‐risk patients with congenital heart disease (CHD), a complete closure of an intracardiac defect/shunt is not possible for a variety of reasons. We report our experiences with an interventional approach for shunt‐reduction using various modifications of a self‐fabricated Amplatzer device in our institution. Methods: Retrospective analysis of patients with CHD having received an interventional partial shunt occlusion since 09/2005. Results: Five patients, mean age 18.6(3.4–66) years, mean weight 36.4(14–102) kg, have been treated. In three patients (3.4, 3.9, 66 years) with an atrial septal defect (ASD) and a restrictive left ventricle (LV) (n = 1) or pulmonary arterial hypertension (PAH) (n = 2), respectively, an Amplatzer Septal Occluder (ASO) with a predilated (n = 2) or a presutured (n = 1) central hole was implanted. After successful immediate volume release in all, the balloon‐dilated holes closed spontaneously during mid‐term follow‐up, pulmonary artery (PA) pressure and LV function remained normal. Two patients (2.7 and 17 years) with a Fontan circulation and severe cyanosis (saturation ≤80%) due to a large fenestration and elevated PA pressures received a partial occlusion of their shunt by implanting a centrally stented ASO or Amplatzer Vascular plug. After a follow‐up of 31 and 39 months both stents remained patent under oral anticoagulation, oxygen saturation remained >85% with PA pressures unchanged, and both patients were in good clinical conditions. Conclusions: In patients with an ASD and significant PAH and/or restrictive LV physiology as well as in Fontan patients with a large surgically created fenestration but failing Fontan circulation, a partial closure with a self‐fenestrated Amplatzer device can be a feasible and successful therapeutic option. Balloon‐dilated fenestrations in the Amplatzer device tend to close spontaneously during follow‐up. Nonresorbable sutures or stenting can ensure patency of the created holes.Keywords
This publication has 18 references indexed in Scilit:
- Percutaneous management of a Fontan fenestration: In search for the ideal restriction—occlusion deviceCatheterization and Cardiovascular Interventions, 2009
- Efficacy and long‐term patency of fenestrated amplatzer devices in childrenCatheterization and Cardiovascular Interventions, 2007
- Closure of extracardiac Fontan fenestration by using the covered Cheatham Platinum stentCatheterization and Cardiovascular Interventions, 2007
- Feasibility and clinical impact of transcatheter closure of interatrial communications after a fenestrated Fontan procedure: Medium‐term outcomesCatheterization and Cardiovascular Interventions, 2007
- Role of atrial septostomy in the treatment of children with pulmonary arterial hypertensionHeart, 2006
- Closure of a moderately large atrial septal defect with a self‐fabricated fenestrated Amplatzer septal occluder in an 85‐year‐old patient with reduced diastolic elasticity of the left ventricleCatheterization and Cardiovascular Interventions, 2005
- Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defectCatheterization and Cardiovascular Interventions, 2005
- Fenestrated Amplatzer device for percutaneous creation of interatrial communication in patients after Fontan operationCatheterization and Cardiovascular Interventions, 2003
- A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defectsCatheterization and Cardiovascular Interventions, 2002
- Clinical Outcome of Fenestrated Fontan Patients After ClosureCirculation, 2000